Show simple item record

dc.contributor.authorYanik, Keramettin
dc.contributor.authorGuluzade, Emin
dc.contributor.authorBilgin, Kemal
dc.contributor.authorKaradag, Adil
dc.contributor.authorEroglu, Cafer
dc.contributor.authorBirinci, Asuman
dc.contributor.authorGunaydin, Murat
dc.date.accessioned2020-06-21T13:45:22Z
dc.date.available2020-06-21T13:45:22Z
dc.date.issued2015
dc.identifier.issn1972-2680
dc.identifier.urihttps://doi.org/10.3855/jidc.6300
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14047
dc.descriptionWOS: 000366288500007en_US
dc.descriptionPubMed: 26517483en_US
dc.description.abstractIntroduction: The aim of this study was to investigate the effectiveness of ceftaroline against agents frequently isolated from respiratory tract and wound infections. Methodology: The study included a total of 250 strains isolated from various clinical specimens, among which were Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysagalactiae, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catharralis. The bacteria were identified using the matrix-assisted laser desorption/ionization time-of-flight method and conventional methods. The bacteria's antibiotic susceptibility was tested using appropriate broth microdilution. Mueller-Hinton broth with 4% lysed horse blood, Haemophilus test medium broth, and Mueller-Hinton broth were used. Ceftaroline fosamil results at the minimum inhibitory concentration (MIC) were evaluated using Clinical and Laboratory Standards Institute (CLSI) criteria. For quality assurance, E. coli ATCC 35218, S. aureus ATCC 29213, S. aureus ATCC 43300, S. pneumoniae ATCC 49619, H. influenzae ATCC 49766, H. influenzae ATCC 10211, and H. influenzae ATCC 49247 standard strains were used. Results: According to CLSI criteria, resistance was not detected in any strains. Due to the absence of CLSI criteria for M. catharralis, the susceptibility state for this bacterium was not evaluated. The various strains' MIC50-MIC90 values were as follows: for S. pyogenes, 0.01-50.06; for S. agalactiae, 0.03-0.125; for S. dysagalactiae, 0.03-0.06; for S. pneumoniae, 0.06-0.125; for H. influenzae, 0.015-0.125; and for M. catharralis, 0.5-1. Conclusions: The results indicate that ceftaroline is quite effective against bacteria that are frequently isolated from respiratory tract and wound infections.en_US
dc.language.isoengen_US
dc.publisherJ Infection Developing Countriesen_US
dc.relation.isversionof10.3855/jidc.6300en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectS. pneumoniaeen_US
dc.subjectH. influenzaeen_US
dc.subjectM. catharralisen_US
dc.subjectstreptococcusen_US
dc.subjectceftarolineen_US
dc.subjectMICen_US
dc.titleCeftaroline activity on certain respiratory tract and wound infection agents at the minimum inhibitory concentration levelen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume9en_US
dc.identifier.issue10en_US
dc.identifier.startpage1086en_US
dc.identifier.endpage1090en_US
dc.relation.journalJournal of Infection in Developing Countriesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record